See Antiyaya_yes original comment in "Many People Don't Realize..." thread, but I will copy and paste below:
"Why I have continually added to my already huge positions of NWBO: the German, the German, and the German.
Most people would agree with me that the German would not approve the use of DCVax-L for all forms of brain cancer patients if it does not believe that it is safe (most of us agree) and have at least some efficacy (yes I am saying just "some").
So the key here is that DCVax-L is safe and has some efficacy for a deadly cancer which has no effective treatment. That alone is enough to make the Germans to approve its commercial use.
What that really means? Well, if the current Ph3 trial were not concluded successfully according to the plan (for example, the p value greater than 0.05), and thus it might be difficult for the US FDA (USA) to approve it, the German would still allow DCVax-L to be used as it specified in its original approval.
BECAUSE IT IS NO REASON FOR THE GERMANS TO DEPRIVE PATIENTS FROM HAVING A SAFE AND EFFECTIVE (ALTHOUGH MIGHT NOT BE AS HIGH AS FDA WANTS) VACCINE WHICH CAN SAFE OR EXTEND LIVES OF PATIENTS WHILE ENJOYING IMPROVE QUALITY OF LIFE!
In conclusion, I believe even if DCVax-L ph 3 would fail, the company will continually enjoy revenues from Germany market, and other European markets (other EU countries will follow the German sooner or latter). Accordingly, your investment and my investment in NWBO today is safe and will be safe at least if it does not give you a substantial financial gain.
I have not included the more powerful (though earlier) and much higher market potential DCVax-Direct in this investment thesis, nor potential partnerships or buyout, etc., nor short squeeze, nor increased institutional involvement, etc.
BTW, did you know that patients who got shot of DCVax-L have mostly experienced fever. Yes, I am talking about FEVER, that means it is working! (no joke)"
It will eventually send that wall street #$%$ AF to say "I am wrong, I am a loser" as he has done repeatedly. He is a shameless pig, and because his shameless and senseless personality, shorts and short hedge funds love him. Unfortunately, he has been more wrong than right in his coin trowing gambling, and in the case of NWBO, he is already a loser (just not many people have realized).
Remember this is the worst scenario that I can come up with. That is in the worst scenario, the stock price should be at least $10; in the good scenario (i.e., us approval of DCVax-L), the stock price should be at least $50 ~ $100; in the best scenario (i.e., approval of DCVax-L and D), the stock price should be at least $1,000 (not joking)
If only a more substantial number of people were convinced by this line of thinking. If DCvax is truly a Yervoy-like drug--one for which the benefit is only apparent after many months have elapsed--then NWBO is onto something. Or it could be one of the many drugs on which a few outliers do well but there is no overall clinical benefit.
drugs like this come with possibly severe side effects, and Yervoy is no exception. The drug can provoke powerful autoimmune reactions in which the immune system attacks normal cells in the body. In clinical trials, nearly 13% of patients taking Yervoy had severe or fatal autoimmune reaction
No, according to my discussion with him, he (Antiyaya) is a staunch believer of the success of DCVax-L in treating brain cancer, i.e., he thinks the existing ph 3 trail will be successful at a time much earlier than most of us anticipates.
He just gave a worst case scenario. That means, if even such worst case did occur (again we don't believe it would), the current share price is still undervalued.
If I am wrong, please correct me, Antiyaya.